Ahlskog JE - Search Results

1

Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease.

Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H. Boeve BF, et al. Among authors: ahlskog je. Brain. 2007 Nov;130(Pt 11):2770-88. doi: 10.1093/brain/awm056. Epub 2007 Apr 5. Brain. 2007. PMID: 17412731 Review.

2

Guamanian neurodegenerative disease: investigation of the calcium metabolism/heavy metal hypothesis.

Ahlskog JE, Waring SC, Kurland LT, Petersen RC, Moyer TP, Harmsen WS, Maraganore DM, O'Brien PC, Esteban-Santillan C, Bush V. Ahlskog JE, et al. Neurology. 1995 Jul;45(7):1340-4. doi: 10.1212/wnl.45.7.1340. Neurology. 1995. PMID: 7617195

3

Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Collins SJ, et al. Among authors: ahlskog je. J Neurol Neurosurg Psychiatry. 1995 Feb;58(2):167-73. doi: 10.1136/jnnp.58.2.167. J Neurol Neurosurg Psychiatry. 1995. PMID: 7876846 Free PMC article.

4

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

Uitti RJ, Rajput AH, Ahlskog JE, Offord KP, Schroeder DR, Ho MM, Prasad M, Rajput A, Basran P. Uitti RJ, et al. Among authors: ahlskog je. Neurology. 1996 Jun;46(6):1551-6. doi: 10.1212/wnl.46.6.1551. Neurology. 1996. PMID: 8649547

5

Guamanian neurodegenerative disease: are diabetes mellitus and altered humoral immunity clues to pathogenesis?

Ahlskog JE, Petersen RC, Waring SC, Esteban-Santillan C, Craig UK, Maraganore DM, Lennon VA, Kurland LT. Ahlskog JE, et al. Neurology. 1997 May;48(5):1356-62. doi: 10.1212/wnl.48.5.1356. Neurology. 1997. PMID: 9153473

6

Autonomic failure in Guamanian neurodegenerative disease.

Low PA, Ahlskog JE, Petersen RC, Waring SC, Esteban-Santillan C, Kurland LT. Low PA, et al. Among authors: ahlskog je. Neurology. 1997 Oct;49(4):1031-4. doi: 10.1212/wnl.49.4.1031. Neurology. 1997. PMID: 9339685

7

Clinical presentation and pharmacological therapy in corticobasal degeneration.

Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, Riley DE. Kompoliti K, et al. Among authors: ahlskog je. Arch Neurol. 1998 Jul;55(7):957-61. doi: 10.1001/archneur.55.7.957. Arch Neurol. 1998. PMID: 9678313 Clinical Trial.

8

Neurodegenerative diseases of Guam: analysis of TAU.

Pérez-Tur J, Buée L, Morris HR, Waring SC, Onstead L, Wavrant-De Vrièze F, Crook R, Buée-Scherrer V, Hof PR, Petersen RC, McGeer PL, Delacourte A, Hutton M, Siddique T, Ahlskog JE, Hardy J, Steele JC. Pérez-Tur J, et al. Among authors: ahlskog je. Neurology. 1999 Jul 22;53(2):411-3. doi: 10.1212/wnl.53.2.411. Neurology. 1999. PMID: 10430438

9

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration.

Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, Dickson DW, Kokmen E, Petersen RC. Boeve BF, et al. Among authors: ahlskog je. Neurology. 1999 Sep 11;53(4):795-800. doi: 10.1212/wnl.53.4.795. Neurology. 1999. PMID: 10489043

10

Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls.

Tsuboi Y, Ahlskog JE, Apaydin H, Parisi JE, Dickson DW. Tsuboi Y, et al. Among authors: ahlskog je. Neurology. 2001 Nov 13;57(9):1675-8. doi: 10.1212/wnl.57.9.1675. Neurology. 2001. PMID: 11706110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

292 results

Search Page